Unconscious breath holding at high altitude can cause acute heart conditions for climbers

April 9, 2018 by Nicole Graham, University of Alberta
Stephen Busch in the Himalayas during a research expedition in October 2016. Using data collected during the trip, Busch found that mountain climbers who unconsciously hold their breath at high altitudes may suffer heart arrythmias and sleep apnea that could be harmful to their health. Credit: Craig Steinback

Climbing at high altitude may increase your risk of developing acute heart conditions, according to new physiology research out of the University of Alberta.

Stephen Busch, a researcher in the Faculty of Kinesiology, Sport, and Recreation, recently published findings that show the development of periodic arrhythmic episodes at an altitude of 5,050 metres when people hold their breath.

"We focused on breath holding because it is something that we all do on a regular basis without even thinking about it," said Busch. "When we're in a pro-arrhythmia environment, like 5,050 metres up Mount Everest, this simple, unconscious action can have major health implications."

According to Busch, the arrhythmias are due to conflicting messages between the sympathetic nervous system, which is responsible for the "fight-or-flight response," and the "rest-and-digest response" better known as the parasympathetic nervous system.

At , sympathetic and parasympathetic activity works in a reciprocal fashion on the heart—when one increases, the other decreases, and vice versa. This allows for precise control of the heart to numerous stressors to which we're unconsciously exposed.

But breath holding is a unique stressor that causes an increase in both sympathetic and parasympathetic activity. Busch said he believes the conflict is triggered by a specialized group of cells, known as peripheral chemoreceptors, that monitor chemical changes in our blood. In this case, the chemical change at altitude is a lack of oxygen.

The experiment

To better understand how breath holding affects the sympathetic nervous system, Busch tested the heart rate response in 14 lowlanders both at sea level and at an elevation of 5,050 metres, and eight Nepalese Sherpa—an ethnic group found mainly in the Himalayas who are acclimatized to high altitudes—at 5,050 metres.

The results showed that breath holding at sea level did not produce abnormal heart responses. However, after spending several days at high altitude, lowlanders developed arrhythmias when they held their breath.

Busch hypothesized that the arrhythmias were due to the chemoreceptors becoming sensitive over time at high altitude, causing them to fire more often.

Busch tested this hypothesis by giving seven of the 14 lowlanders additional oxygen immediately prior to a secondary breath hold at high altitude, working under the assumption that supplementary oxygen would stop the chemoreceptors from activating, thereby reducing the stress to the heart during breath holding.

The abnormal heart responses vanished with the additional oxygen, returning lowlanders back to their sea-level values.

"This indicates that long-term chemoreceptor activation at altitude may promote a 'pro-arrhythmia' environment during stressful periods through a conflict between the sympathetic and ," said Busch.

He noted the Sherpas did not show any abnormal heart responses to breath holding at altitude. He believes this is a result of evolutionary adaptations that allow them to tolerate altitude better than acclimatizing climbers.

Affects sleep

Busch suggests the condition may also cause irregular sleep patterns, although further research is needed.

"When you're climbing a mountain, the last thing you need is poor performance due to lack of sleep," said Busch, who added he thinks the breath holds may translate to other altitude-related conditions such as Cheyne-Stokes respiration, a condition similar to sleep apnea.

"The lack of sleep climbers experience because of the apneas increases performance risks while placing unnecessary stress on the body," said Busch. "This is a major concern for climbers who want to summit big mountains like Everest."

Busch and colleagues are now working on trying to replicate the results they saw at in the Neurovascular Health Lab at the U of A. By doing so, they can use the same testing they implemented as part of this research project to test a climber's sensitivity to before actually climbing in the mountains. This may help climbers be more informed about their risk of developing arrhythmias, which is especially important with climbers who have pre-existing conditions. Currently, no predictive tests exist.

The study, "Chemoreflex Mediated Arrhythmia During Apnea at 5050m in Low but not High Altitude Natives" was published last December in the Journal of Applied Physiology. Data were collected by Busch and associate professor Craig Steinback as part of a research excursion to the Himalayas in October 2016.

Explore further: Drinking alcohol makes your heart race

More information: Stephen A. Busch et al. Chemoreflex Mediated Arrhythmia during Apnea at 5050m in Low but not High Altitude Natives, Journal of Applied Physiology (2017). DOI: 10.1152/japplphysiol.00774.2017

Related Stories

Drinking alcohol makes your heart race

March 18, 2018
The more alcohol you drink, the higher your heart rate gets, according to research presented today at EHRA 2018 Congress, organized by the European Society of Cardiology.

Do most Mount Everest climbers use medications, and should they?

December 14, 2016
The ethics of using medications to improve performance and increase the likelihood of success in high-altitude climbing remains a controversial topic, and a new study that asked climbers of Mount Everest their opinions and ...

US scientists head to Mount Everest for research

April 20, 2012
(AP) -- A team of American scientists and researchers flew to the Mount Everest region on Friday to set up a laboratory at the base of the world's highest mountain to study the effects of high altitude on humans.

Himalayan powerhouses: How Sherpas have evolved superhuman energy efficiency

May 22, 2017
Sherpas have evolved to become superhuman mountain climbers, extremely efficient at producing the energy to power their bodies even when oxygen is scarce, suggests new research published today in the Proceedings of the National ...

Recommended for you

Genomic autopsy can help solve unexplained cardiac death

August 15, 2018
Molecular autopsies can reveal genetic risk factors in young people who unexpectedly die, but proper interpretation of the results can be challenging, according to a recent study published in Circulation.

Neonatal pig hearts can heal from heart attack

August 15, 2018
While pigs still cannot fly, researchers have discovered that the hearts of newborn piglets do have one remarkable ability. They can almost completely heal themselves after experimental heart attacks.

Fifty percent of cardiovascular patients suffer from multiple diseases

August 15, 2018
New research led by The University of Western Australia has revealed that one in two patients admitted to hospital with a cardiovascular disease is suffering from multiple chronic medical conditions which required complex ...

Innovative triple pill significantly lowers blood pressure, study finds

August 14, 2018
A new low dose three in one pill to treat hypertension could transform the way high blood pressure is treated around the world.

Drug repurposing study sheds light on heart disease risk

August 14, 2018
A team led by researchers at Brigham and Women's Hospital has developed a computational technique to reveal the unknown side effects—both good and bad—of hundreds of drugs. That knowledge could help pharmacologists discover ...

Rethinking the stroke rule 'time is brain'

August 13, 2018
In 1993, neurologist Camilo R. Gomez, MD, coined a phrase that for a quarter century has been a fundamental rule of stroke care: "Time is brain!"


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.